Showing results (311-320 of 351) with videos related to
Sort By:
Pageof 36
Internal Medicine (Tokyo, Japan)|October 18, 2019
Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal LiverNobuhiko Ogasawara, Satoshi Saitoh, Hideyuki Denpou, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 13, 2012
Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dLNaoki Matsumoto, Yasuji Arase, Yuya Seko, et al.Liver Cancer|July 11, 2020
Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall PrognosisYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.Journal of Medical Virology|April 20, 2011
Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapyTakahiro Azakami, C Nelson Hayes, Hitomi Sezaki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 26, 2024
Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapyYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary reportYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.Internal Medicine (Tokyo, Japan)|June 26, 2020
Diagnosis and Resection Treatment of Triplet Hepatocellular Carcinomas with a non-B non-C Background in a Middle Aged Man over a Period of 6-yearsAkira Kajiwara, Keiichi Kinowaki, Norio Akuta, et al.Journal of Gastroenterology|March 4, 2018
Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infectionNorio Akuta, Joji Toyota, Yoshiyasu Karino, et al.Internal Medicine (Tokyo, Japan)|May 8, 2024
Long-term Favorable Efficacy of Regular and Repeated Hospitalizations with a Personalized Diet and Exercise Treatment for Steatotic Liver DiseaseNorio Akuta, Yusuke Kawamura, Hitomi Sezaki, et al.Hepatology International|July 24, 2015
Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitisYusuke Kawamura, Satoshi Saitoh, Yasuji Arase, et al.Pageof 36